<p>Cells were pretreated with propofol (100 μM) for 1 h or UGT1A siRNA for 24 h. Then cells were exposed to β-lap (5 μM) for 24 h and collected. Cell apoptosis was assessed by TUNEL assay. (A) Cell apoptosis in HCT116 cells with propofol/NAC/catalase pretreatment; (B) Cell apoptosis in HT29 cells with propofol/NAC/catalase pretreatment; (C) Cell apoptosis in HT29 cells with siRNA/NAC/catalase pretreatment. Results are presented as mean ± 3 SEM of at least three independent experiments (*P<0.05, **P<0.01, β-lap treatment vs. control cells; #P<0.05, NAC pretreatment vs. corresponding β-lap only; $P<0.05, catalase pretreatment vs. corresponding β-lap only).</p
BACKGROUND AND PURPOSE: NAD(P)H: quinone oxidoreductase 1 (NQO1) mediated quinone reduction and subs...
<p>(A) Isolated human primary neutrophils and (B) ATRA (1 μM)-differentiated granulocytic HL60 cells...
BACKGROUND: Propofol (2, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent administered...
<p>Cells were pretreated with propofol (100 μM) for 1 h or UGT1A siRNA for 24 h. Then, cells were ex...
<p>Cells were pretreated with propofol (100 μM) for 1 h or UGT1A siRNA for 24 h. Then, Cells were ex...
<p>Cells were pretreated with UGT1A siRNA or non-specific siRNA (negative control) for 72 hours, or ...
<p>Cells were pretreated with UGT1A siRNA or scrambled siRNA (negative control) for 24 h, or pretrea...
<p>Cells were pretreated with UGT1A siRNA or non-specific siRNA (negative control) for 24 hours, or ...
<div><p>β-lapachone (β-lap), an NAD(P)H:quinone oxidoreductase 1 (NQO1) targeting antitumor drug can...
<p>(A) Apoptotic cells in control group, Propofol group, TG group and Propofol+TG group were analyze...
<p>Cells were pretreated with UGT1A siRNA or non-specific siRNA (negative control) for 48 hours, or ...
<p>Results of Propofol Induced Apoptosis in Cancer Cells with Different Kras Gene Types.</p
Propofol (2, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent administered to induce a...
<p>(a-j) Detection of apoptosis with Annexin V-FITC and propidium iodide staining. Cells were precon...
NAD(P)H: quinone oxidoreductase 1 (NQO1) mediated quinone reduction and subsequent UDP-glucuronosylt...
BACKGROUND AND PURPOSE: NAD(P)H: quinone oxidoreductase 1 (NQO1) mediated quinone reduction and subs...
<p>(A) Isolated human primary neutrophils and (B) ATRA (1 μM)-differentiated granulocytic HL60 cells...
BACKGROUND: Propofol (2, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent administered...
<p>Cells were pretreated with propofol (100 μM) for 1 h or UGT1A siRNA for 24 h. Then, cells were ex...
<p>Cells were pretreated with propofol (100 μM) for 1 h or UGT1A siRNA for 24 h. Then, Cells were ex...
<p>Cells were pretreated with UGT1A siRNA or non-specific siRNA (negative control) for 72 hours, or ...
<p>Cells were pretreated with UGT1A siRNA or scrambled siRNA (negative control) for 24 h, or pretrea...
<p>Cells were pretreated with UGT1A siRNA or non-specific siRNA (negative control) for 24 hours, or ...
<div><p>β-lapachone (β-lap), an NAD(P)H:quinone oxidoreductase 1 (NQO1) targeting antitumor drug can...
<p>(A) Apoptotic cells in control group, Propofol group, TG group and Propofol+TG group were analyze...
<p>Cells were pretreated with UGT1A siRNA or non-specific siRNA (negative control) for 48 hours, or ...
<p>Results of Propofol Induced Apoptosis in Cancer Cells with Different Kras Gene Types.</p
Propofol (2, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent administered to induce a...
<p>(a-j) Detection of apoptosis with Annexin V-FITC and propidium iodide staining. Cells were precon...
NAD(P)H: quinone oxidoreductase 1 (NQO1) mediated quinone reduction and subsequent UDP-glucuronosylt...
BACKGROUND AND PURPOSE: NAD(P)H: quinone oxidoreductase 1 (NQO1) mediated quinone reduction and subs...
<p>(A) Isolated human primary neutrophils and (B) ATRA (1 μM)-differentiated granulocytic HL60 cells...
BACKGROUND: Propofol (2, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent administered...